BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3670291)

  • 21. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus.
    Fulton R; Plumb M; Shield L; Neil JC
    J Virol; 1990 Apr; 64(4):1675-82. PubMed ID: 2157050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new look at the origins of gibbon ape leukemia virus.
    McKee J; Clark N; Shapter F; Simmons G
    Virus Genes; 2017 Apr; 53(2):165-172. PubMed ID: 28220345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
    LoSardo JE; Cupelli LA; Short MK; Berman JW; Lenz J
    J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.
    Smith CD; Baglia LA; Curristin SM; Ruddell A
    J Virol; 1994 Oct; 68(10):6232-42. PubMed ID: 8083963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D; Casey JW
    Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
    Mertz JA; Mustafa F; Meyers S; Dudley JP
    J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
    Granger SW; Fan H
    J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic characterization of a new gibbon ape leukemia virus isolate: seroepidemiologic assessment of an outbreak of gibbon leukemia.
    Krakower JM; Tronick SR; Gallagher RE; Gallo RC; Aaronson SA
    Int J Cancer; 1978 Dec; 22(6):715-20. PubMed ID: 82546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleotide sequence analysis and enhancer function of long terminal repeats associated with an endogenous African green monkey retroviral DNA.
    Kessel M; Khan AS
    Mol Cell Biol; 1985 Jun; 5(6):1335-42. PubMed ID: 3861934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of the proposed gibbon ape leukemia virus binding site in Pit1 suggests that other regions are important for infection.
    Chaudry GJ; Eiden MV
    J Virol; 1997 Oct; 71(10):8078-81. PubMed ID: 9311908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.
    Zaiman AL; Lewis AF; Crute BE; Speck NA; Lenz J
    J Virol; 1995 May; 69(5):2898-906. PubMed ID: 7707514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CArG, CCAAT, and CCAAT-like protein binding sites in avian retrovirus long terminal repeat enhancers.
    Zachow KR; Conklin KF
    J Virol; 1992 Apr; 66(4):1959-70. PubMed ID: 1312613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences.
    Thornell A; Hallberg B; Grundström T
    J Virol; 1991 Jan; 65(1):42-50. PubMed ID: 1985206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.
    Baum C; Itoh K; Meyer J; Laker C; Ito Y; Ostertag W
    J Virol; 1997 Sep; 71(9):6323-31. PubMed ID: 9261349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cDNAs encoding the gibbon ape leukaemia virus receptor from susceptible and non-susceptible murine cells.
    Wilson CA; Farrell KB; Eiden MV
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1901-8. PubMed ID: 8046392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.
    Brooks AR; Levy-Wilson B
    Mol Cell Biol; 1992 Mar; 12(3):1134-48. PubMed ID: 1545795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate early enhancer.
    Fickenscher H; Stamminger T; Rüger R; Fleckenstein B
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():107-23. PubMed ID: 2543734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel enhancer element mediating calcium-dependent induction of gene expression in response to either epidermal growth factor or activation of protein kinase C.
    Lenormand P; Pribnow D; Rodland KD; Magun BE
    Mol Cell Biol; 1992 Jun; 12(6):2793-803. PubMed ID: 1588971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral and cellular factors governing hamster cell infection by murine and gibbon ape leukemia viruses.
    Wilson CA; Eiden MV
    J Virol; 1991 Nov; 65(11):5975-82. PubMed ID: 1717711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.